Photodynamic therapy-induced AP-1 survival signaling (WP3611)

Homo sapiens

Open in new tab Open in NDEx
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads
Photodynamic therapy may induce an acute stress response mediated by mitogen-activated protein kinase kinase kinase 5 (MAP3K5), its downstream MAPKs that target c-Jun N-terminal kinase (JNK, MAPK8) and p38MAPK, and the transcription factors of the activator protein 1 (AP-1) family.

Authors

Ruud Weijer , Kristina Hanspers , Friederike Ehrhart , Alex Pico , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited By

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Disease Ontology

cancer

Pathway Ontology

altered regulatory pathway

Participants
Query Drugst.One

Label Type Compact Identifier Comment
TRAF6 GeneProduct ncbigene:7189
PDGFRA GeneProduct ncbigene:5156
MAPK11 GeneProduct ncbigene:5600
JUNB GeneProduct ncbigene:3726
IL6 GeneProduct ncbigene:3569
HSP90AA1 GeneProduct ncbigene:3320
IL2 GeneProduct ncbigene:3558
TRAF5 GeneProduct ncbigene:7188
IFNG GeneProduct ncbigene:3458
TNFSF10 GeneProduct ncbigene:8743
TNF GeneProduct ncbigene:7124
CCND1 GeneProduct ncbigene:595
TRAF2 GeneProduct ncbigene:7186
MAPK13 GeneProduct ncbigene:5603
FOS GeneProduct ncbigene:2353
MMP2 GeneProduct ncbigene:4313
MAPK12 GeneProduct ncbigene:6300
MAP2K7 GeneProduct ncbigene:5609
MAPK14 GeneProduct ncbigene:1432
MAP2K3 GeneProduct ncbigene:5606
MAP3K5 GeneProduct ncbigene:4217
MAP2K4 GeneProduct ncbigene:6416
MAP2K6 GeneProduct ncbigene:5608
TNFRSF1A GeneProduct ncbigene:7132
TNF GeneProduct ncbigene:7124
FOS GeneProduct ncbigene:2353
TNF GeneProduct ncbigene:7124
CCNA2 GeneProduct ncbigene:890
CCNE1 GeneProduct ncbigene:898
EGFR GeneProduct ncbigene:1956
HBEGF GeneProduct ncbigene:1839
FGF7 GeneProduct ncbigene:2252
FASLG GeneProduct ncbigene:356
FAS GeneProduct ncbigene:355
RB1 GeneProduct ncbigene:5925
TP53 GeneProduct ncbigene:7157
CDKN1A GeneProduct ncbigene:1026
BCL2 GeneProduct ncbigene:596
BCL2L1 GeneProduct ncbigene:598
BCL2L11 GeneProduct ncbigene:10018
BCL3 GeneProduct ncbigene:602
CDKN2A GeneProduct ncbigene:1029
BID GeneProduct ncbigene:637
CFLAR GeneProduct ncbigene:8837
NFE2L2 GeneProduct ncbigene:4780
BAK1 GeneProduct ncbigene:578
BCL2L11 GeneProduct ncbigene:10018
BCL2L1 GeneProduct ncbigene:598
TP53 GeneProduct ncbigene:7157
BAX GeneProduct ncbigene:581
MCL1 GeneProduct ncbigene:4170
BCL2 GeneProduct ncbigene:596
BMF GeneProduct ncbigene:90427
ELK1 GeneProduct ncbigene:2002
JUN GeneProduct ncbigene:3725
ATF2 GeneProduct ncbigene:1386
MAPK8 GeneProduct ncbigene:5599

References

  1. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Broekgaarden M, Weijer R, van Gulik TM, Hamblin MR, Heger M. Cancer Metastasis Rev. 2015 Dec;34(4):643–90. PubMed Europe PMC Scholia
  2. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells. Weijer R, Broekgaarden M, van Golen RF, Bulle E, Nieuwenhuis E, Jongejan A, et al. BMC Cancer. 2015 Dec 26;15:1014. PubMed Europe PMC Scholia